Showing results (871-880 of 1,074) with videos related to
Sort By:
Pageof 108
Therapeutic Advances in Neurological Disorders|April 30, 2015
The emerging role of tacrolimus in myasthenia gravisJennifer L Cruz, Marissa L Wolff, Adam J Vanderman, et al.Therapeutic Advances in Neurological Disorders|July 3, 2015
Subcutaneous immunoglobulin in treating inflammatory neuromuscular disordersMin-Suk Yoon, Ralf Gold, Antonios KerasnoudisTherapeutic Advances in Neurological Disorders|July 3, 2015
The iontophoretic transdermal system formulation of sumatriptan as a new option in the acute treatment of migraine: a perspectiveMichail Vikelis, Konstantinos C Spingos, Alan M RapoportTherapeutic Advances in Neurological Disorders|July 24, 2018
New developments in brain metastasesAnna S Berghoff, Matthias PreusserTherapeutic Advances in Neurological Disorders|August 8, 2018
Immunological and non-immunological effects of stem cell-derived extracellular vesicles on the ischaemic brainThorsten R Doeppner, Mathias Bähr, Bernd Giebel, et al.Therapeutic Advances in Neurological Disorders|August 8, 2018
Anti-inflammatory treatments for stroke: from bench to bedsideAntoine Drieu, Damien Levard, Denis Vivien, et al.Therapeutic Advances in Neurological Disorders|August 8, 2018
Treatment of glioblastoma in adultsWolfgang Wick, Matthias Osswald, Antje Wick, et al.Therapeutic Advances in Neurological Disorders|May 17, 2017
Health-related quality of life outcomes from botulinum toxin treatment in hemifacial spasmDaniel Weiss, Justine Sturm, Leonhard Hieber, et al.Therapeutic Advances in Neurological Disorders|April 29, 2017
Reliability and validity of the Attributional Style Questionnaire- Survey in people with multiple sclerosisIan I Kneebone, Sophie J DewarTherapeutic Advances in Neurological Disorders|April 29, 2017
Peginterferon beta-1a reduces disability worsening in relapsing-remitting multiple sclerosis: 2-year results from ADVANCEScott D Newsome, Bernd C Kieseier, Shifang Liu, et al.Pageof 108